BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 24057573)

  • 21. Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine.
    Byrd GD; Ogden MW
    J Mass Spectrom; 2003 Jan; 38(1):98-107. PubMed ID: 12526011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
    Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
    Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Children are particularly vulnerable to environmental tobacco smoke exposure: Evidence from biomarkers of tobacco-specific nitrosamines, and oxidative stress.
    Chao MR; Cooke MS; Kuo CY; Pan CH; Liu HH; Yang HJ; Chen SC; Chiang YC; Hu CW
    Environ Int; 2018 Nov; 120():238-245. PubMed ID: 30103123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
    Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
    Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of tobacco-derived compounds in human pancreatic juice.
    Prokopczyk B; Hoffmann D; Bologna M; Cunningham AJ; Trushin N; Akerkar S; Boyiri T; Amin S; Desai D; Colosimo S; Pittman B; Leder G; Ramadani M; Henne-Bruns D; Beger HG; El-Bayoumy K
    Chem Res Toxicol; 2002 May; 15(5):677-85. PubMed ID: 12018989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
    Czoli CD; Hammond D
    Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development, validation, and application of a liquid chromatography-tandem mass spectrometry method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human hair.
    Yao L; Yang J; Guan YF; Liu BZ; Zheng SJ; Wang WM; Zhu XL; Zhang ZD
    Anal Bioanal Chem; 2012 Nov; 404(8):2259-66. PubMed ID: 22926132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary biomarkers to assess exposure of cats to environmental tobacco smoke.
    McNiel EA; Carmella SG; Heath LA; Bliss RL; Le KA; Hecht SS
    Am J Vet Res; 2007 Apr; 68(4):349-53. PubMed ID: 17397288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
    Murphy SE; Carmella SG; Idris AM; Hoffmann D
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG; Ye M; Upadhyaya P; Hecht SS
    Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.
    Stepanov I; Hecht SS; Duca G; Mardari I
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):7-11. PubMed ID: 16434579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
    Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
    Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
    Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
    Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.